This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, Y.-C. Articles by Hunter, D. J. Search for Related Content PubMed PubMed Citation Articles by Chen, Y.-C. Articles by Hunter, D. J.

Sequence Variants of Toll-Like Receptor 4 and Susceptibility to Prostate Cancer

¹ Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; ² Department of Nutrition and ³ Program in Molecular and Genetic Epidemiology, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts

Requests for reprints: Yen-Ching Chen, Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115. Fax: 617-525-2008; E-mail: karen.chen{at}channing.harvard.edu.

Chronic inflammation has been hypothesized to be a risk factor for prostate cancer. The Toll-like receptor 4 (TLR4) presents the bacterial lipopolysaccharide (LPS), which interacts with ligand-binding protein and CD14 (LPS receptor) and activates expression of inflammatory genes through nuclear factor-B and mitogen-activated protein kinase signaling. A previous case-control study found a modest association of a polymorphism in the TLR4 gene [11381G/C, GG versus GC/CC: odds ratio (OR), 1.26] with risk of prostate cancer. We assessed if sequence variants of TLR4 were associated with the risk of prostate cancer. In a nested case-control design within the Health Professionals Follow-up Study, we identified 700 participants with prostate cancer diagnosed after they had provided a blood specimen in 1993 and before January 2000. Controls were 700 age-matched men without prostate cancer who had had a prostate-specific antigen test after providing a blood specimen. We genotyped 16 common (>5%) single nucleotide polymorphisms (SNP) discovered in a resequencing study spanning TLR4 to test for association between sequence variation in TLR4 and prostate cancer. Homozygosity for the variant alleles of eight SNPs was associated with a statistically significantly lower risk of prostate cancer (TLR4_1893, TLR4_2032, TLR4_2437, TLR4_7764, TLR4_11912, TLR4_16649, TLR4_17050, and TLR4_17923), but the TLR4_15844 polymorphism corresponding to 11381G/C was not associated with prostate cancer (GG versus CG/CC: OR, 1.01; 95% confidence interval, 0.79-1.29). Six common haplotypes (cumulative frequency, 81%) were observed; the global test for association between haplotypes and prostate cancer was statistically significant (² = 14.8 on 6 degrees of freedom; P = 0.02). Two common haplotypes were statistically significantly associated with altered risk of prostate cancer. Inherited polymorphisms of the innate immune gene TLR4 are associated with risk of prostate cancer. (Cancer Res 2005; 65(24): 11771-8)

This article has been cited by other articles:

				Y.-C. Chen, E. Giovannucci, P. Kraft, and D. J. Hunter Association between Genetic Polymorphisms of Macrophage Scavenger Receptor 1 Gene and Risk of Prostate Cancer in the Health Professionals Follow-up Study Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 1001 - 1003. [Abstract] [Full Text] [PDF]

				H. Yang, J. Gu, X. Lin, H. B. Grossman, Y. Ye, C. P. Dinney, and X. Wu Profiling of Genetic Variations in Inflammation Pathway Genes in Relation to Bladder Cancer Predisposition Clin. Cancer Res., April 1, 2008; 14(7): 2236 - 2244. [Abstract] [Full Text] [PDF]

				V. Andreani, G. Gatti, L. Simonella, V. Rivero, and M. Maccioni Activation of Toll-like Receptor 4 on Tumor Cells In vitro Inhibits Subsequent Tumor Growth In vivo Cancer Res., November 1, 2007; 67(21): 10519 - 10527. [Abstract] [Full Text] [PDF]

				Y.-C. Chen, E. Giovannucci, P. Kraft, R. Lazarus, and D. J. Hunter Association between Toll-Like Receptor Gene Cluster (TLR6, TLR1, and TLR10) and Prostate Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1982 - 1989. [Abstract] [Full Text] [PDF]

				X. Liu, F. R. Schumacher, S. J. Plummer, E. Jorgenson, G. Casey, and J. S. Witte trans-Fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant Carcinogenesis, June 1, 2007; 28(6): 1232 - 1236. [Abstract] [Full Text] [PDF]

				I. Cheng, S. J. Plummer, G. Casey, and J. S. Witte Toll-Like Receptor 4 Genetic Variation and Advanced Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 352 - 355. [Abstract] [Full Text] [PDF]

				A. A. Quintar, F. D. Roth, A. L. D. Paul, A. Aoki, and C. A. Maldonado Toll-Like Receptor 4 in Rat Prostate: Modulation by Testosterone and Acute Bacterial Infection in Epithelial and Stromal Cells Biol Reprod, November 1, 2006; 75(5): 664 - 672. [Abstract] [Full Text] [PDF]